Showing results (1-10 of 111) with videos related to
Sort By:
Pageof 12
Behring Institute Mitteilungen|December 1, 1993
C1q inhibitor (chondroitin-4-sulfate proteoglycan): structure and functionB Ghebrehiwet, D K GalanakisThe Journal of Clinical Investigation|January 1, 1994
A unique property of a plasma proteoglycan, the C1q inhibitor. An anticoagulant state resulting from its binding to fibrinogenD K Galanakis, B GhebrehiwetClinical Immunology (Orlando, Fla.)|March 17, 1999
The receptor for the globular "heads" of C1q, gC1q-R, binds to fibrinogen/fibrin and impairs its polymerizationP D Lu, D K Galanakis, B Ghebrehiwet, et al.Thrombosis Research|May 15, 1995
Plasma cryoprecipitation studies: major increase in fibrinogen yield by albumin enrichment of plasmaD K GalanakisHematology/Oncology Clinics of North America|October 1, 1992
Fibrinogen anomalies and disease. A clinical updateD K GalanakisSeminars in Thrombosis and Hemostasis|January 1, 1992
Anticoagulant albumin fragments that bind to fibrinogen/fibrin: possible implicationsD K GalanakisJournal of Immunology (Baltimore, Md. : 1950)|July 15, 1986
Production and characterization of a murine monoclonal IgM antibody to human C1q receptor (C1qR)B GhebrehiwetClinical Immunology and Immunopathology|February 1, 1984
The release of lysosomal enzymes from human polymorphonuclear leukocytes by human C3eB GhebrehiwetPageof 12